IVERIC bio, Inc. - Common Stock (NQ:ISEE)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IVERIC bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

41 Stocks Moving In Friday's Mid-Day Session ↗

September 10, 2021

Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic...

Via Benzinga

Here's Why Iveric Bio Stock Is Rocketing Higher Today ↗

September 10, 2021

Mixed results from Apellis Pharmaceuticals are good news for Iveric Bio's geographic atrophy program.

Via The Motley Fool

ISEE Stock: Why Rival Eye Drug Developer’s Disappointment Is a Boon to IVERIC bio ↗

September 10, 2021

IVERIC bio (ISEE) stock is rocketing higher on Friday and there's a couple of catalysts behind the shares' positive movement today.

Via InvestorPlace

Why Are Iveric Bio Shares Surging In Premarket Friday? ↗

September 10, 2021

Iveric Bio Inc (NASDAQ:ISEE) stock is trading...

Via Benzinga

Why IVERIC Bio Shares Are Soaring Today ↗

September 10, 2021

IVERIC Bio Inc (NASDAQ: ISEE) is trading significantly higher Friday after Apellis Pharmaceuticals Inc (NASDAQ: APLS) reported results from its Phase 3 DERBY and OAKS studies...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; Kroger Tops Q2 Views ↗

September 10, 2021

Following the market opening Friday, the Dow traded down 0.15% to 34,827.04 while the NASDAQ rose 0.32% to 15,296.61. The S&P also rose, gaining 0.03% to 4,494.53. The U.S....

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For September 10, 2021 ↗

September 10, 2021

Upgrades According to JonesTrading, the prior rating for Orchid Island Capital Inc (NYSE:

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 10, 2021

Gainers IVERIC bio (NASDAQ:ISEE) stock increased by 65.36% to $14.37 during Friday's pre-market session. The company's market cap stands at $1.4 billion. T2...

Via Benzinga

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test ↗

September 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

20 Stocks Moving in Friday's Pre-Market Session ↗

September 10, 2021

Gainers IVERIC bio, Inc. (NASDAQ: ISEE) rose 29.6% to $11.26 in pre-market trading. Iveric Bio recently reported inducement grants under Nasdaq Listing Rule 5635(c)(4). T2...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 09, 2021

Gainers IVERIC bio (NASDAQ:ISEE) shares ...

Via Benzinga

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

September 02, 2021

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...

Via Benzinga

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 02, 2021

From IVERIC bio, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2021 ↗

August 19, 2021

Upgrades According to DA Davidson, the prior rating for PaySign Inc (NASDAQ:

Via Benzinga

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗

August 31, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

Understanding IVERIC bio's Unusual Options Activity ↗

August 17, 2021

On Tuesday, shares of IVERIC bio (NASDAQ:ISEE) saw unusual options activity. After the option alert, the stock price moved up to $9.3. Sentiment: BULLISH Option Type: SWEEP...

Via Benzinga

Iveric Bio to Present at the H.C. Wainwright Ophthalmology Virtual Conference

August 10, 2021

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio to Participate in the 2021 Wedbush PacGrow Healthcare Virtual Conference on August 11, 2021

August 04, 2021

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio Reports Second Quarter 2021 Operational Highlights and Financial Results

August 04, 2021

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

August 03, 2021

From IVERIC bio, Inc.

Via Business Wire

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

Iveric Bio to Report Second Quarter 2021 Financial Results and Host Conference Call on Wednesday, August 4, 2021

July 28, 2021

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio Completes Patient Enrollment of GATHER2 Pivotal Clinical Trial of Zimura® Ahead of Schedule

July 26, 2021

From IVERIC bio, Inc.

Via Business Wire

Iveric Bio Appoints Christopher Simms as Chief Commercial Officer

July 19, 2021

From IVERIC bio, Inc.

Via Business Wire

The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study ↗

July 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data ↗

July 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Iveric Bio Raises $100M Via Equity To Fund Zimura Development In Geographic Atrophy ↗

July 13, 2021

Iveric bio Inc (NASDAQ: ISEE) priced its underwritten public offering of 11.6 million shares at $8.60 per share, representing a discount of 4.6% from the last close...

Via Benzinga

IVERIC bio, Inc. Announces Pricing of $100 Million Public Offering of Common Stock

July 12, 2021

From IVERIC bio, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 12, 2021

Gainers SCWorx (NASDAQ:WORX) shares rose...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.